Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Women’s Cancers

    Vanderbilt-Ingram Cancer Center Encourages HPV Vaccination

    Wednesday, January 27th, 2016

    Contact: Dagny Stuart, (615) 936-7245 Dagny.stuart@vanderbilt.edu In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in urging increased HPV vaccination for the prevention of cancer. Experts at VICC, in collaboration with colleagues at the other cancer centers, recognize […]

    VICC investigators land Komen breast cancer grants

    Thursday, October 1st, 2015

    Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. The 2015 grants will provide nearly […]

    Ovarian cancer foundation honors VUMC’s Khabele

    Thursday, September 24th, 2015

    Dineo Khabele, M.D., associate professor of Obstetrics and Gynecology and Cancer Biology, has been named to the Scientific Advisory Committee of the Ovarian Cancer Research Fund (OCRF). Khabele joins Celeste Leigh Pearce, Ph.D., MPH, associate professor in the Department of Epidemiology at the University of Michigan, and Daniel Powell Jr., Ph.D., research associate professor of […]

    Drug combos enhance ovarian cancer cell death

    Monday, August 24th, 2015

    Ovarian cancer is often diagnosed at an advanced stage and frequently develops resistance to platinum chemotherapy. Identifying new drug combinations to overcome platinum resistance is a critical clinical challenge. They report in the Journal of Ovarian Research that combined thymoquinone and cisplatin had synergistic anti-tumor effects in cultured cells. The drug combination reduced tumor burden and […]

    New type of trial shows promise for several cancers

    Monday, August 24th, 2015

    Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. The new clinical trial showed promising results in […]

    NCI report shows U.S. cancer deaths on decline

    Thursday, April 2nd, 2015

    The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. The report from the National Cancer Institute, a division of the National Institutes of Health, […]

    Cancer survival improvements vary by age, race

    Thursday, February 26th, 2015

    Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. The study was published online recently […]

    Pink Out! game set for Sunday, Feb. 8

    Thursday, February 5th, 2015

    The stands inside Memorial Gymnasium are expected to resemble a sea of pink as fans don pink attire for the Vanderbilt Commodores Women’s Basketball game Sunday, Feb. 8, at noon. The Commodores will play the University of Kentucky Wildcats during the annual Pink Out! Game, which is designed to raise awareness of breast cancer and […]

    Gene linked to breast cancer therapy response

    Friday, November 21st, 2014

    A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. The study was published online in the Journal of Clinical Investigation. Luis Schwarz, M.D., and Emily Fox, Ph.D., served as co-first authors of the study, led by senior author Carlos […]

    More breast cancer patients choose mastectomy

    Friday, November 21st, 2014

    Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that is confined to one breast, a Vanderbilt study shows.

    Next Page »

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us